Nick Haggar – Head Commercial Operations Western Europe, Sandoz France
Sandoz has set important trends in the pharmaceutical market, first by creating a leading global generics business…
Address: 49, avenue Georges Pompidou, 92593 Levallois-Perret Cedex,France
Tel: +33 (0) 1 49 64 48 00
Sandoz is a global generics leader. We save and improve lives by developing, producing and distributing high-quality, affordable pharmaceuticals. Thanks to our global network, Sandoz medicines are now available to 90% of people worldwide. In addition to direct cost savings to patients, we contribute to the stability of healthcare systems worldwide and free up resources for new and innovative medicines.
Sandoz SAS is the generics branch of Novartis Group in France.
At Sandoz, we make far more than just traditional off-patent medicines. We stand out from the crowd thanks to our ability to develop and produce a wide range of differentiated products, ranging from complex delivery systems for standard generics through to modern biopharmaceutical medicines (biosimilars).
Sandoz has set important trends in the pharmaceutical market, first by creating a leading global generics business…
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…
A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how…
A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s…
Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in…
With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe…
French firm LFB is targeting the lucrative US market with its hemophilia products and recently received two FDA…
French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679…
David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi’s vaccines division, was appointed…
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would…
In a recent interview with Financial Times, Sanofi CEO Paul Hudson set out to clarify some recent comments that the…
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are…